Drugplain

Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen 30 mg/mL

Avobenzone, Homosalate, Octisalate and Octocrylene · CREAM · L'Oreal USA Products Inc

No Recall History
Plain English

Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen is a cream containing avobenzone, homosalate, octisalate and octocrylene at 30 mg/mL, taken topical. Manufactured by L'Oreal USA Products Inc.

Key Facts

Brand Name
Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen
Generic Name
Avobenzone, Homosalate, Octisalate and Octocrylene
NDC Code (Product)
82046-222
Manufacturer
L'Oreal USA Products Inc
Strength
30 mg/mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
03/20/2026

Recall History

No Recall History

Frequently Asked Questions

What is Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen used for?

Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen contains Avobenzone, Homosalate, Octisalate and Octocrylene. It is a cream taken topical. Consult your doctor for specific uses.

Is Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen a controlled substance?

Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen?

The generic name for Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen is Avobenzone, Homosalate, Octisalate and Octocrylene. There are 11 other brand versions of Avobenzone, Homosalate, Octisalate and Octocrylene.

What is the NDC code for Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen 30 mg/mL?

The NDC (National Drug Code) for Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen 30 mg/mL is 82046-222, listed by L'Oreal USA Products Inc.

Product NDC

82046-222

Package NDC

82046-222-01

Other Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)